# OnCo record aop-health (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/aop-health/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "aop-health" ;
  schema:name "AOP Health"@en ;
  schema:alternateName "AOP Orphan Pharmaceuticals AG"@en, "AOP Orphan"@en, "AOP Orphan Pharmaceuticals"@en ;
  schema:description "AOP Health is a Vienna rare-disease company that brought ropeginterferon alfa-2b (Besremi) to the European market for polycythaemia vera and runs trials in myeloproliferative neoplasms and other rare conditions."@en ;
  schema:url <https://onco.cc/companies/aop-health/>, <https://www.aop-health.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.aop-health.com>, <https://clinicaltrials.gov/search?lead=AOP%20Orphan%20Pharmaceuticals> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "AT" ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:drugs <https://onco.cc/drugs/ropeginterferon-alfa-2b/> ;
  onco:terms <https://onco.cc/terms/pivotal-trial/>, <https://onco.cc/terms/clinical-trial/> .